SiliconInvestor
     Advanced Search   [ sign in ]

register
Register

 Biotech / Medical : Micrologix biotech

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Larry G. who wrote (672)2/18/2000 4:29:00 AM
From: Graham DellaireRead Replies (1) of 792
 
The spectre of production of peptides in large enough quantities for internal/intravenous use will probably seriously delay any internal drug.

Topical drugs are a great way to use the MBI peptides before they figure out how to really ramp up production.

Serious competition will come from small molecule drugs created by the pharmas... it makes sense now why no pharma has co-ventured with MBI. They have their own stable of products and they are shying away from the peptide sythesis/scale-up problems.

Good news on the ability of MBI to do large scale manufacture of the peptides will be the best news of all!

Graham
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.